Provided by Tiger Trade Technology Pte. Ltd.

Ardelyx

3.89
-0.0100-0.26%
Pre-market: 3.920.0300+0.77%04:00 EDT
Volume:2.88M
Turnover:11.28M
Market Cap:969.34M
PE:-17.10
High:3.97
Open:3.92
Low:3.88
Close:3.90
52wk High:8.40
52wk Low:3.86
Shares:249.19M
Float Shares:219.00M
Volume Ratio:0.75
T/O Rate:1.31%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2275
EPS(LYR):-0.2556
ROE:-38.61%
ROA:-4.25%
PB:6.51
PE(LYR):-15.22

Loading ...

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Apr 30

Ardelyx Announces Abstract Accepted for Poster Presentation at the NKF’s Spring Clinical Meetings

GlobeNewswire
·
Apr 27

Ardelyx (ARDX) Receives a Buy from Piper Sandler

TIPRANKS
·
Apr 24

Earning Preview: Ardelyx this quarter’s revenue is expected to increase by 20.17%, and institutional views are bullish

Earnings Agent
·
Apr 24

Ardelyx Announces Abstract Exploring IBS-C Treatment Patterns Accepted for Poster Presentation at Digestive Disease Week 2026

GlobeNewswire
·
Apr 23

Ardelyx files Form 3 for Chief Legal Officer Felecia Ettenberg

Reuters
·
Apr 23

Ardelyx names Felecia Ettenberg chief legal officer, replacing retiring Elizabeth Grammer

Reuters
·
Apr 20

Press Release: Ardelyx Appoints Biopharmaceutical Veteran, Felecia W. Ettenberg, as Chief Legal Officer

Dow Jones
·
Apr 20

Ardelyx CEO Michael Raab sells 41,668 shares for $261,956.86

Reuters
·
Apr 18

Ardelyx schedules quarterly results conference call and webcast

Reuters
·
Apr 16

Ardelyx to Report First Quarter 2026 Financial Results on April 30, 2026

GlobeNewswire
·
Apr 16

Ardelyx files beneficial ownership Form 3 for Chief Medical Officer Rajani Dinavahi

Reuters
·
Apr 04

Press Release: Rajani Dinavahi, MD, Appointed Chief Medical Officer of Ardelyx

Dow Jones
·
Apr 01

Ardelyx President and CEO Michael Raab disposes of USD 243,330 in common shares

Reuters
·
Mar 19

Will Ardelyx’s (ARDX) IBSRELA Data Shift Its Competitive Position In IBS-C Treatments?

Simply Wall St.
·
Mar 14

Ardelyx Announces Recipients of the 2026 Derek Forfang Patient Advocate Award

GlobeNewswire
·
Mar 12

Ardelyx (ARDX) Valuation Check After Recent Share Price Weakness And Growth Expectations

Simply Wall St.
·
Mar 10

Ardelyx Announces Publication of a Review Article Demonstrating Rapid and Meaningful Symptom Relief with Tenapanor in IBS-C

GlobeNewswire
·
Mar 10

Zevra Therapeutics Names Justin Renz CFO

MT Newswires Live
·
Mar 05

Ardelyx to Participate in Upcoming Investor Conferences

GlobeNewswire
·
Mar 04